No Data
Clinical AI Platforms Expand Globally Amid Regulatory and Market Tailwinds
RadNet | 10-K/A: Annual report (Amendment)
GE HealthCare to Feature Latest Advancements in Diagnostic Accuracy and Patient-centered Breast Care at SBI 2025 Breast Cancer Imaging Symposium
RadNet's (NASDAQ:RDNT) Investors Will Be Pleased With Their Solid 240% Return Over the Last Five Years
RadNet, Inc. Announces Date of Its First Quarter 2025 Financial Results Conference Call
RadNet's ICAD Deal to Expand Its Digital Health Services and Geographic Presence, Truist Says
G3636G : $iCAD Inc (ICAD.US)$ "With over 1,500 healthcare provider locations, facilitating over 8 million annual mammograms in 50 countries, iCAD's installed base and strong sales, engineering and marketing capabilities will provide us with immediate broad and valuable customer relationships and commercialization capabilities that can accelerate our existing DeepHealth objectives," said Dr. Howard Berger, President and CEO of RadNet. "This business combination is expected to accelerate our global leadership and commitment to AI-powered breast cancer screening, and positions us to further advance population health."
The deal will add iCAD's global network of over 1,500 healthcare locations to RadNet's DeepHealth platform, expanding access to advanced screening technologies. The companies believe the combination will speed up innovation, improve early cancer detection, and enhance patient outcomes worldwide